title: Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remission.
authors.forename: D
authors.initials: D
authors.lastname: Blaise
authors.forename: D
authors.initials: D
authors.lastname: Maraninchi
authors.forename: M
authors.initials: M
authors.lastname: Michallet
authors.forename: J
authors.initials: J
authors.lastname: Reiffers
authors.forename: J P
authors.initials: JP
authors.lastname: Jouet
authors.forename: N
authors.initials: N
authors.lastname: Milpied
authors.forename: A
authors.initials: A
authors.lastname: Devergie
authors.forename: M
authors.initials: M
authors.lastname: Attal
authors.forename: J J
authors.initials: JJ
authors.lastname: Sotto
authors.forename: M
authors.initials: M
authors.lastname: Kuentz
authors.forename: N
authors.initials: N
authors.lastname: Ifrah
authors.forename: C
authors.initials: C
authors.lastname: Dauriac
authors.forename: P
authors.initials: P
authors.lastname: Bordigoni
authors.forename: N
authors.initials: N
authors.lastname: Gratecos
authors.forename: F
authors.initials: F
authors.lastname: Guilhot
authors.forename: D
authors.initials: D
authors.lastname: Guyotat
authors.forename: E
authors.initials: E
authors.lastname: Gluckman
authors.forename: J P
authors.initials: JP
authors.lastname: Vernant
mesh_terms: D016026:Bone Marrow Transplantation; D002066:Busulfan / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D012074:Remission Induction; D019172:Transplantation Conditioning; D014916:Whole-Body Irradiation
chemical_list: D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D002066:Busulfan